gallopamil has been researched along with Angor Pectoris in 48 studies
Gallopamil: Coronary vasodilator that is an analog of iproveratril (VERAPAMIL) with one more methoxy group on the benzene ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The anti-ischemic properties and tolerability of a slow-release formulation (SR) of gallopamil were investigated in 118 patients with exercise-inducible ST-segment depression and stable angina pectoris in this double-blind, randomized, placebo-controlled, multicenter study." | 9.07 | Efficacy and tolerability of slow-release gallopamil in patients with stable exercise-inducible angina pectoris. ( Emmerich, K; Gülker, H; Koch, HP; Kottkamp, H; Minge, C, 1992) |
| "We studied the effects of slow-release gallopamil two-times 100 mg on exercise-induced ST-segment depression, as well as on the incidence of spontaneous myocardial ischemia detected by long-term ECG monitoring for 48 h in patients with coronary artery disease and stable angina pectoris." | 9.06 | [Treatment of stress-induced and spontaneous myocardial ischemia in coronary disease patients with slow-release gallopamil--preliminary results of an open study]. ( Reuschel-Janetschek, E; Steinbeck, C; von Arnim, T, 1989) |
| "The effects of the calcium-channel-blocking agent Gallopamil (D 600) were assessed in 20 patients with stable exertional angina pectoris in a randomized placebo-controlled double-blind protocol using serial exercise tests." | 9.05 | [Acute and long-term effects of gallopamil (D 600) in stable angina pectoris--a randomized double-blind study]. ( Bette, L; Rettig, G; Schieffer, H; Sen, S, 1983) |
| "Gallopamil appears to be safe, well tolerated and effective in the long term control of angina pectoris; its effects are fully developed at 3 months and persist unchanged after 2 years." | 7.68 | [Long-term treatment of stable angina pectoris with gallopamil]. ( Centanni, M; Dessì-Fulgheri, P; Ferretti, GF; Mattei, O; Mazzara, D; Pupita, G; Rappelli, A; Rimatori, C; Russo, P, 1992) |
| "Efficacy and tolerance of gallopamil (Procorum) were investigated over a period of 1 year under practice conditions in a total of 455 patients (254 male, 201 female), aged 62 years (male) and 66 (female) on an average, with electrocardiographically confirmed coronary heart disease." | 7.67 | [Multicenter long-term study of gallopamil in patients with coronary heart disease]. ( Schiemann, J; Sućić, M, 1984) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 6.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| "The anti-ischemic properties and tolerability of a slow-release formulation (SR) of gallopamil were investigated in 118 patients with exercise-inducible ST-segment depression and stable angina pectoris in this double-blind, randomized, placebo-controlled, multicenter study." | 5.07 | Efficacy and tolerability of slow-release gallopamil in patients with stable exercise-inducible angina pectoris. ( Emmerich, K; Gülker, H; Koch, HP; Kottkamp, H; Minge, C, 1992) |
| "In 18 patients (17 male and 1 female, 40 to 63 years old) with coronary heart disease, a randomized double-blind study was carried out to investigate in comparison to placebo, the antiischemic effects of 5, 10 and 20 mg isosorbide dinitrate (ISDN) alone and in combination with gallopamil (G: 25 and 50 mg) or 80 mg propranolol (P: 80 mg) on the ischemic ST-segment-depression in standardized exercise ECGs." | 5.06 | [The anti-ischemic effect of isosorbide dinitrate alone and in combination with gallopamil and propranolol]. ( Hopf, R; Kaltenbach, M; Sthler-Klich, HM, 1989) |
| "We studied the effects of slow-release gallopamil two-times 100 mg on exercise-induced ST-segment depression, as well as on the incidence of spontaneous myocardial ischemia detected by long-term ECG monitoring for 48 h in patients with coronary artery disease and stable angina pectoris." | 5.06 | [Treatment of stress-induced and spontaneous myocardial ischemia in coronary disease patients with slow-release gallopamil--preliminary results of an open study]. ( Reuschel-Janetschek, E; Steinbeck, C; von Arnim, T, 1989) |
| ", gallopamil retard represents a suitable medication for the treatment of both symptomatic and asymptomatic ischemic episodes, as could be demonstrated in patients with coronary heart disease ascertained by angiography, positive exercise testing, and more than five ischemic episodes in Holter monitoring over 48 h." | 5.06 | [Effectiveness of retard gallopamil in patients with stress-induced ST-segment depression and silent myocardial ischemias]. ( Barbato, G; Klein, H; Lichtlen, PR, 1989) |
| "Two-dimensional echocardiography was used to determine global and regional left ventricular function in 32 patients treated with gallopamil (methoxyverapamil) for angina pectoris." | 5.06 | Echocardiographic evaluation of the effects of gallopamil on left ventricular function. ( Ben-Ari, E; Drory, Y; Fisman, EZ; Friedman, BA; Kellermann, JJ; Pines, A; Shiner, RJ, 1988) |
| "In 12 male patients with angiographically confirmed coronary heart disease and stable angina the antianginal effects of 50 mg Gallopamil have been studied in comparison with 10 mg Nifedipine and placebo." | 5.05 | [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo]. ( Drews, H; Hopf, R; Kaltenbach, M, 1984) |
| "The effects of the calcium-channel-blocking agent Gallopamil (D 600) were assessed in 20 patients with stable exertional angina pectoris in a randomized placebo-controlled double-blind protocol using serial exercise tests." | 5.05 | [Acute and long-term effects of gallopamil (D 600) in stable angina pectoris--a randomized double-blind study]. ( Bette, L; Rettig, G; Schieffer, H; Sen, S, 1983) |
| "Gallopamil appears to be safe, well tolerated and effective in the long term control of angina pectoris; its effects are fully developed at 3 months and persist unchanged after 2 years." | 3.68 | [Long-term treatment of stable angina pectoris with gallopamil]. ( Centanni, M; Dessì-Fulgheri, P; Ferretti, GF; Mattei, O; Mazzara, D; Pupita, G; Rappelli, A; Rimatori, C; Russo, P, 1992) |
| "Efficacy and tolerance of gallopamil (Procorum) were investigated over a period of 1 year under practice conditions in a total of 455 patients (254 male, 201 female), aged 62 years (male) and 66 (female) on an average, with electrocardiographically confirmed coronary heart disease." | 3.67 | [Multicenter long-term study of gallopamil in patients with coronary heart disease]. ( Schiemann, J; Sućić, M, 1984) |
| "Tedisamil is a new bradycardic agent proven to exert antiischemic and antiarrhythmic effects by blockade of the cellular cardiac repolarization K+ currents as well as of multiple neuronal and vascular K+ currents (Ito, Ik, and K+ATP)." | 2.69 | Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists. ( Hamm, C; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J, 2000) |
| "Gallopamil (GSR) is a new calcium-channel blocker." | 2.67 | Slow-release gallopamil in patients with stable effort angina. ( Cherchi, A; Lai, C; Onnis, E; Solinas, R, 1992) |
| "Gallopamil was well tolerated." | 2.67 | Gallopamil slow release: a double blind study of twice daily versus once daily treatment in chronic stable angina. ( Chong, EM; Markus, HS; Wilcox, RG, 1992) |
| " After 24 h, the dosage was increased to 0." | 2.67 | Administration of gallopamil by long-term venous infusion in spontaneous angina. A single-blind, self-controlled study versus placebo. ( Cappelletti, F; Carlon, R; Maiolino, P; Ometto, R; Pedon, L; Vincenzi, M; Zanchetta, M, 1991) |
| " For each period of treatment the gallopamil plasma concentrations were dosed during the ergometric test." | 2.67 | [Efficacy and duration of effect of two delayed-action preparations of gallopamil in patients with exercise angina]. ( Dovellini, EV; Fantoccoli, D; Fazzini, PF; Leoncini, M; Pucci, P; Sarro, F, 1990) |
| "or gallopamil 75 mg t." | 2.66 | Objective evaluation of gallopamil in patients with chronic stable angina. Exercise testing, Holter monitoring, cross-sectional echocardiography and plasma levels. ( Chiddo, A; Lagioia, R; Mangini, SG; Mastropasqua, F; Ricci, A; Rizzon, P; Scrutinio, D, 1989) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 2.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| "The effect of a controlled-release formulation of isosorbide-5-mononitrate (IS-5-MN) was studied in patients with coronary heart disease (CHD), with the aim of comparing the acute effect with that after chronic administration on parameters of ischemia." | 1.28 | Lack of tolerance after chronic administration of controlled-release isosorbide-5-mononitrate. Interaction of nitrate and gallopamil. ( Adam, WE; Grossmann, G; Stauch, M; Wanjura, D, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (56.25) | 18.7374 |
| 1990's | 20 (41.67) | 18.2507 |
| 2000's | 1 (2.08) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khurmi, NS | 1 |
| O'Hara, MJ | 1 |
| Bowles, MJ | 1 |
| Subramanian, VB | 1 |
| Raftery, EB | 1 |
| Hopf, R | 3 |
| Drews, H | 1 |
| Kaltenbach, M | 3 |
| Kroesen, P | 1 |
| Rettig, G | 2 |
| Sen, S | 3 |
| Schieffer, H | 2 |
| Bette, L | 2 |
| Sućić, M | 1 |
| Schiemann, J | 1 |
| Perticone, F | 1 |
| Borelli, DA | 1 |
| Pugliese, F | 1 |
| Maio, R | 1 |
| Costa, R | 1 |
| Cosco, C | 1 |
| Ceravolo, R | 1 |
| Mattioli, PL | 1 |
| Simonelli, P | 1 |
| Papa, A | 1 |
| Macciocchi, B | 1 |
| Auriemma, F | 1 |
| Vetrano, A | 1 |
| Scaletta Romeo di Santillo, M | 1 |
| Ceriello, A | 1 |
| Mitrovic, V | 1 |
| Oehm, E | 1 |
| Thormann, J | 1 |
| Pitschner, H | 1 |
| Hamm, C | 1 |
| Carboni, GP | 1 |
| Saltarocchi, ML | 1 |
| Risa, AL | 1 |
| Scardovi, AB | 1 |
| Zanchi, E | 1 |
| Prati, PL | 1 |
| Cherchi, A | 1 |
| Lai, C | 1 |
| Onnis, E | 1 |
| Solinas, R | 1 |
| Steinbeck, G | 1 |
| Reuschel-Janetschek, E | 2 |
| Kottkamp, H | 1 |
| Gülker, H | 1 |
| Emmerich, K | 1 |
| Koch, HP | 2 |
| Minge, C | 1 |
| Pupita, G | 1 |
| Mattei, O | 1 |
| Mazzara, D | 1 |
| Centanni, M | 1 |
| Ferretti, GF | 1 |
| Rimatori, C | 1 |
| Dessì-Fulgheri, P | 1 |
| Rappelli, A | 1 |
| Russo, P | 1 |
| Vilchez, FG | 1 |
| Villarroel, T | 1 |
| Ruano Calvo, J | 1 |
| Vazquez de Prada, JA | 1 |
| Martin-Duran, R | 1 |
| San Jose, JM | 1 |
| Pajaron, A | 1 |
| Rettig, GF | 2 |
| Jakob, M | 2 |
| Zanolla, L | 1 |
| Carbonieri, E | 1 |
| Rossi, L | 1 |
| Marino, P | 1 |
| Zardini, P | 1 |
| Markus, HS | 1 |
| Chong, EM | 1 |
| Wilcox, RG | 1 |
| Marraccini, P | 1 |
| Orsini, E | 1 |
| Brunelli, C | 1 |
| Nassi, G | 1 |
| Ghigliotti, G | 1 |
| Iannetti, M | 1 |
| Caponnetto, S | 1 |
| L'Abbate, A | 1 |
| Lazzeroni, E | 1 |
| Morozzi, L | 1 |
| Campana, M | 1 |
| Botti, G | 1 |
| Musso, P | 1 |
| Ottello, B | 1 |
| Pinnavaia, A | 1 |
| Giammaria, M | 1 |
| Mussio, R | 1 |
| Aquaro, G | 1 |
| Heisel, A | 2 |
| Carlon, R | 1 |
| Cappelletti, F | 1 |
| Zanchetta, M | 1 |
| Pedon, L | 1 |
| Ometto, R | 1 |
| Maiolino, P | 1 |
| Vincenzi, M | 1 |
| Lagioia, R | 4 |
| Fila, GT | 1 |
| Ramunni, G | 1 |
| Mastropasqua, F | 4 |
| Scrutinio, D | 4 |
| Rizzon, P | 5 |
| Iliceto, S | 1 |
| Caiati, C | 2 |
| Piccinni, G | 1 |
| Tota, F | 1 |
| De Martino, G | 1 |
| Marangelli, V | 1 |
| Pucci, P | 1 |
| Fantoccoli, D | 1 |
| Dovellini, EV | 1 |
| Leoncini, M | 1 |
| Sarro, F | 1 |
| Fazzini, PF | 1 |
| Stauch, M | 1 |
| Grossmann, G | 1 |
| Wanjura, D | 1 |
| Adam, WE | 1 |
| Reiterer, W | 1 |
| Rafflenbeul, W | 1 |
| Jost, S | 1 |
| Berger, C | 1 |
| Lichtlen, P | 1 |
| Mangini, SG | 3 |
| Ricci, A | 2 |
| Chiddo, A | 3 |
| Sthler-Klich, HM | 1 |
| Steinbeck, C | 1 |
| von Arnim, T | 1 |
| Fleischer, K | 1 |
| Forster, A | 1 |
| Mohler, C | 1 |
| Schulz, PC | 1 |
| Tillmanns, H | 1 |
| Zimmermann, R | 1 |
| Kapp, M | 1 |
| Rauch, B | 1 |
| Neumann, FJ | 1 |
| Schlumpp, K | 1 |
| Bubeck, B | 1 |
| Georgi, P | 1 |
| Kübler, W | 1 |
| Loskot, F | 1 |
| Novotny, P | 1 |
| Sucic, P | 1 |
| Schneider, G | 1 |
| Zenker, GD | 1 |
| Rödl, S | 1 |
| Genger, K | 1 |
| Barbato, G | 1 |
| Klein, H | 1 |
| Lichtlen, PR | 1 |
| Sangiorgio, P | 2 |
| Rubboli, A | 2 |
| Brunelli, D | 1 |
| Bracchetti, D | 2 |
| Specchia, G | 3 |
| De Servi, S | 3 |
| Ferrario, M | 3 |
| Ghio, S | 3 |
| Fulvi, M | 1 |
| Vogel, W | 1 |
| Fisman, EZ | 1 |
| Pines, A | 1 |
| Ben-Ari, E | 1 |
| Shiner, RJ | 1 |
| Drory, Y | 1 |
| Friedman, BA | 1 |
| Kellermann, JJ | 1 |
| Eichstädt, H | 1 |
| Danne, O | 1 |
| Gutmann, M | 1 |
| Langer, M | 1 |
| Felix, R | 1 |
| Schmutzler, H | 1 |
| Loliva, F | 1 |
| Venezia, M | 1 |
| Tartagni, F | 1 |
| Marchetti, G | 1 |
| Maiello, L | 1 |
| Dondi, M | 1 |
| Franchi, R | 1 |
| Magnani, B | 1 |
| Cobelli, F | 1 |
| Tavazzi, L | 1 |
| Opasich, C | 1 |
| Riccardi, G | 1 |
| Mussini, A | 1 |
| Angoli, L | 1 |
| Bramucci, E | 1 |
| Bartoli, A | 1 |
| Poma, E | 1 |
| Rondanelli, R | 1 |
1 review available for gallopamil and Angor Pectoris
| Article | Year |
|---|---|
[Procorum].
Topics: Angina Pectoris; Animals; Clinical Trials as Topic; Coronary Disease; Gallopamil; Humans | 1988 |
35 trials available for gallopamil and Angor Pectoris
| Article | Year |
|---|---|
Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Exercise | 1984 |
[Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Bli | 1984 |
[Comparison of the anti-angina effectiveness of gallopamil to isosorbide dinitrate in long-term medication].
Topics: Angina Pectoris; Clinical Trials as Topic; Female; Gallopamil; Humans; Isosorbide Dinitrate; Long-Te | 1983 |
[Acute and long-term effects of gallopamil (D 600) in stable angina pectoris--a randomized double-blind study].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Fe | 1983 |
[An ergometric cross-over evaluation of the anti-ischemic efficacy of amlodipine and gallopamil in stable angina of effort].
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Angina Pectoris; Exercise Test; Female; Gallopamil; H | 1993 |
[Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
Topics: Age Factors; Aged; Angina Pectoris; Coronary Angiography; Coronary Disease; Diltiazem; Drug Evaluati | 1993 |
Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Anti-Arrhythmia Age | 2000 |
Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris.
Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulato | 1992 |
Slow-release gallopamil in patients with stable effort angina.
Topics: Aged; Angina Pectoris; Blood Pressure; Delayed-Action Preparations; Electrocardiography; Exercise Te | 1992 |
Efficacy and tolerability of slow-release gallopamil in patients with stable exercise-inducible angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Electrocardiography; Exercise; Female; Ga | 1992 |
Comparison of acute and steady-state conditions of gallopamil therapy in stable angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Adminis | 1992 |
[The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
Topics: Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Delayed-Action Preparations; Dose-Response | 1992 |
Gallopamil in chronic stable angina: antianginal effect and mechanism of action. A randomized, placebo-controlled, double-blind, cross-over trial.
Topics: Aged; Angina Pectoris; Blood Pressure; Double-Blind Method; Echocardiography; Electrocardiography; E | 1992 |
Gallopamil slow release: a double blind study of twice daily versus once daily treatment in chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Exe | 1992 |
Gallopamil and diltiazem: a double-blind, randomized, cross-over trial in effort ischaemia.
Topics: Adult; Angina Pectoris; Blood Pressure; Diltiazem; Double-Blind Method; Exercise; Exercise Test; Gal | 1992 |
Efficacy and tolerability of gallopamil in coronary heart disease: a double blind cross-over comparison with nifedipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiogr | 1992 |
Comparison of dihydropyridine and phenylalkylamine calcium antagonists in patients with coronary heart disease.
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Female; Gall | 1991 |
Administration of gallopamil by long-term venous infusion in spontaneous angina. A single-blind, self-controlled study versus placebo.
Topics: Adult; Angina Pectoris; Blood Pressure; Coronary Angiography; Electrocardiography, Ambulatory; Femal | 1991 |
Efficacy and duration of the effect of gallopamil sustained release in patients with chronic stable effort angina.
Topics: Aged; Angina Pectoris; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Exercise T | 1991 |
Evaluation of the effects of gallopamil in patients with effort angina by transesophageal atrial pacing two-dimensional echocardiography.
Topics: Aged; Angina Pectoris; Cardiac Pacing, Artificial; Echocardiography; Female; Gallopamil; Humans; Mal | 1990 |
[Efficacy and duration of effect of two delayed-action preparations of gallopamil in patients with exercise angina].
Topics: Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Exercise; Ex | 1990 |
[Effect of calcium antagonists and beta receptor blockers on coronary vessel diameter].
Topics: Angina Pectoris; Atenolol; Coronary Angiography; Coronary Circulation; Coronary Disease; Gallopamil; | 1989 |
Objective evaluation of gallopamil in patients with chronic stable angina. Exercise testing, Holter monitoring, cross-sectional echocardiography and plasma levels.
Topics: Aged; Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Echocardiogra | 1989 |
[The anti-ischemic effect of isosorbide dinitrate alone and in combination with gallopamil and propranolol].
Topics: Adult; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Dru | 1989 |
[Treatment of stress-induced and spontaneous myocardial ischemia in coronary disease patients with slow-release gallopamil--preliminary results of an open study].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Combined Modality Therapy | 1989 |
[Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Top | 1989 |
[Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Exercise Test; Fa | 1989 |
[Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Delayed- | 1989 |
[Randomized comparison between gallopamil and diltiazem in angiography verified coronary heart disease].
Topics: Angina Pectoris; Coronary Angiography; Coronary Disease; Diltiazem; Electrocardiography; Exercise Te | 1989 |
[Effectiveness of retard gallopamil in patients with stress-induced ST-segment depression and silent myocardial ischemias].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Dela | 1989 |
[Gallopamil in stable effort angina. Effects of 2 different dosages].
Topics: Adult; Aged; Angina Pectoris; Female; Gallopamil; Hemodynamics; Humans; Male; Middle Aged; Physical | 1989 |
[Procorum].
Topics: Angina Pectoris; Animals; Clinical Trials as Topic; Coronary Disease; Gallopamil; Humans | 1988 |
Antianginal efficacy of gallopamil in comparison to nifedipine.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Circulation; Double-Blind Method; E | 1988 |
Echocardiographic evaluation of the effects of gallopamil on left ventricular function.
Topics: Aged; Angina Pectoris; Blood Pressure; Blood Volume; Dose-Response Relationship, Drug; Echocardiogra | 1988 |
[Effectiveness and duration of the effect of gallopamil, in single-dose oral administration, in stable exertion angina. A comparison with propranolol and diltiazem].
Topics: Administration, Oral; Aged; Angina Pectoris; Diltiazem; Double-Blind Method; Gallopamil; Humans; Mal | 1986 |
13 other studies available for gallopamil and Angor Pectoris
| Article | Year |
|---|---|
[Multicenter long-term study of gallopamil in patients with coronary heart disease].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Electrocardiography; Female; Gallopa | 1984 |
Slow-release gallopamil evaluated by exercise test and long-term electrocardiography.
Topics: Adult; Aged; Angina Pectoris; Delayed-Action Preparations; Electrocardiography; Exercise Test; Femal | 1992 |
[Long-term treatment of stable angina pectoris with gallopamil].
Topics: Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Echocardiography; Electrocardiography; Exerc | 1992 |
[The effect of gallopamil on myocardial perfusion in angina of effort].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Circulation; Drug Evaluation; Exercise Test; | 1992 |
Lack of tolerance after chronic administration of controlled-release isosorbide-5-mononitrate. Interaction of nitrate and gallopamil.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Delayed-Action Preparations; Drug Interactions; Drug T | 1990 |
[Exercise capacity of coronary heart disease patients in long-term follow-up with gallopamil in comparison with premedication with verapamil].
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Exercise Test; F | 1989 |
Assessment of the mechanism of action of antianginal drugs by the continuous thermodilution method.
Topics: Angina Pectoris; Coronary Circulation; Diltiazem; Gallopamil; Humans; Nifedipine; Physical Exertion; | 1989 |
[Calcium antagonists in angina pectoris].
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Diltiazem; Gallopamil; Humans; | 1988 |
Microperfusion in coronary artery disease under treatment with the calcium antagonist gallopamil.
Topics: Administration, Oral; Angina Pectoris; Coronary Circulation; Coronary Disease; Exercise Test; Female | 1988 |
[Clinical experience with gallopamil in resting and exertional angina].
Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Evaluation; Electrocardiography; Exercise Test; Gal | 1987 |
[Profile of the hemodynamic effect of gallopamil at rest and during exercise by angiocardio-scintigraphic studies: preliminary data].
Topics: Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Gallopamil; Heart; Hemodynamics; Human | 1987 |
[Experience with gallopamil in the treatment of exertional ischemia and in post-infarction].
Topics: Adult; Angina Pectoris; Cardiac Pacing, Artificial; Electrocardiography; Exercise Test; Female; Gall | 1987 |
Coronary haemodynamic effects of short-term intravenous administration of gallopamil in patients with stable exertional angina.
Topics: Angina Pectoris; Coronary Circulation; Female; Gallopamil; Hemodynamics; Humans; Male; Middle Aged; | 1987 |